CHM
Click for more information
10.0% 2.2¢ chimeric therapeutics limited

Ann: CHM CORE-NK vactosertib Phase 1b study re-opens enrolment, page-5

  1. KrushingIt
    40 Posts.
    lightbulb Created with Sketch. 26
    clock Created with Sketch.
    17/05/24
    06:59
    Post #: 73868805
    This is an FDA approved clinical study that is funded by Case Western. What is not to like about this?

    soon we will have ongoing clinical trials (3 X Phase1B and 1 X 1 Phase 1A). The company represents amazing value….
    CHM Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.2¢ 		Change
0.002(10.0%) 		Mkt cap ! $18.39M
Open High Low Value Volume
2.2¢ 2.2¢ 2.0¢ $21.40K 1.025M

Buyers (Bids)

No. Vol. Price($)
5 385342 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 255138 3
View Market Depth
Last trade - 14.29pm 24/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.